Stock BIOQ BIOQUAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bioqual, Inc.

Equities

BIOQ

US09065J1016

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 12:10:54 2024-04-30 pm EDT 		5-day change 1st Jan Change
72.5 USD -3.33% Intraday chart for Bioqual, Inc. -.--% +13.28%
Jan. 23 Bioqual, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023 CI
2023 Bioqual, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2023 CI

Valuation

Fiscal Period: May 2018 2019 2020 2021 2022 2023
Capitalization 1 29.92 32.2 53.66 72.54 62.61 67.98
Enterprise Value (EV) 1 20.01 22.99 59.55 79.44 79.15 79.3
P/E ratio 8.16 x 11.4 x 12.7 x 11.5 x 11.9 x 81.7 x
Yield 1.79% 1.94% 1.83% 1.54% 1.43% 0.66%
Capitalization / Revenue 0.83 x 0.82 x 1.16 x 1.26 x 0.95 x 1.08 x
EV / Revenue 0.56 x 0.58 x 1.28 x 1.38 x 1.2 x 1.27 x
EV / EBITDA 3.33 x 5.16 x 9.33 x 8.01 x 9.6 x 23.5 x
EV / FCF 22.4 x -19.7 x 689 x 393 x 85.9 x 8.5 x
FCF Yield 4.47% -5.09% 0.15% 0.25% 1.16% 11.8%
Price to Book 1.36 x 1.31 x 1.9 x 2.16 x 1.66 x 1.81 x
Nbr of stocks (in thousands) 894 894 894 894 894 894
Reference price 2 33.45 36.00 60.00 81.10 70.00 76.00
Announcement Date 9/12/18 9/13/19 9/14/20 9/17/21 9/24/22 9/22/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: May 2018 2019 2020 2021 2022 2023
Net sales 1 35.88 39.48 46.36 57.68 66.15 62.66
EBITDA 1 6.014 4.456 6.383 9.922 8.245 3.38
EBIT 1 5.273 3.584 5.322 8.557 6.533 1.103
Operating Margin 14.69% 9.08% 11.48% 14.83% 9.88% 1.76%
Earnings before Tax (EBT) 1 5.286 3.709 5.489 8.616 6.577 1.133
Net income 1 3.662 2.831 4.231 6.327 5.261 0.8355
Net margin 10.21% 7.17% 9.13% 10.97% 7.95% 1.33%
EPS 2 4.099 3.169 4.730 7.077 5.880 0.9300
Free Cash Flow 1 0.894 -1.169 0.0864 0.202 0.9215 9.325
FCF margin 2.49% -2.96% 0.19% 0.35% 1.39% 14.88%
FCF Conversion (EBITDA) 14.86% - 1.35% 2.04% 11.18% 275.89%
FCF Conversion (Net income) 24.41% - 2.04% 3.19% 17.52% 1,116.07%
Dividend per Share 2 0.6000 0.7000 1.100 1.250 1.000 0.5000
Announcement Date 9/12/18 9/13/19 9/14/20 9/17/21 9/24/22 9/22/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: May 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 5.89 6.9 16.5 11.3
Net Cash position 1 9.91 9.21 - - - -
Leverage (Debt/EBITDA) - - 0.9225 x 0.6953 x 2.006 x 3.352 x
Free Cash Flow 1 0.89 -1.17 0.09 0.2 0.92 9.33
ROE (net income / shareholders' equity) 17.9% 12.1% 16% 20.5% 14.8% 2.22%
ROA (Net income/ Total Assets) 13.4% 8.2% 8.54% 10.4% 6.99% 1.11%
Assets 1 27.26 34.51 49.52 60.91 75.22 75.55
Book Value Per Share 2 24.70 27.50 31.50 37.50 42.10 42.10
Cash Flow per Share 2 11.40 10.30 11.50 8.630 2.440 8.140
Capex 1 2.07 1.87 2.4 4.41 4.89 2.24
Capex / Sales 5.77% 4.73% 5.19% 7.64% 7.38% 3.58%
Announcement Date 9/12/18 9/13/19 9/14/20 9/17/21 9/24/22 9/22/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
BIOQUAL, INC. Stock Bioqual, Inc.
+13.28% 64.85M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.17% 42.19B
MODERNA, INC. Stock Moderna, Inc.
+10.92% 42.24B
LONZA GROUP AG Stock Lonza Group AG
+44.30% 40.15B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.31B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+5.23% 24.63B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.79% 18.2B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.69% 12.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.13% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.57% 10.4B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. BIOQ Stock
  4. Financials Bioqual, Inc.